(2003) Epidemiology of lung cancer,

(2004) Improved survival in never-smokers vs cu rrent smokers with primary adenocarcinoma of the lung,

(1999) Changing trends of clinical aspects in lung cancer from 1988 to 1996,

(2002) Prognostic factors in non-small cell lung cancer,

(1991) Prognostic factors for surgically treated lung adenocarcinoma patients,with special reference to smoking habits,

(2000) Sex differences in presentation,management,and prognosis of patients with non- small cell lung carcinoma,

(2000) Prognostic factors in advanced non-small cell lung cancer:elevated serum levels of neuron specific enolase indicated poor prognosis,

(1994) Serum neuron specific enolase level as a prognostic factor in non-small cell lung cancer,

(1997) Revisions in the international system for staging lung cancer,

(1997) Ciga rette smoking and histologic type of lung cancer in men,

(1993) Sex differences in lung-cancer risk associated with cigarette smoking,

(1995) Lung cancer in nonsmoking women,

(2004) Is lung cancer in nonsmoker a different disease,

(2001) Chromosomal alter ations in lung adenocarcinoma from smokers and nonsmokers,

(2003) Gene expression in lung adenocarcinoma of smokers and nonsmokers,

(2004) Mutation of the epidermal growth factor receptor gene in lung cancer:biological and clinical implications,

(2004) Smoking and lung cancer survival,

(1990) Smoking history and survival among lung cancer patients,

(1995) Diagnostic usefulness of simul taneous measurement of serum tumor markers in lung cancer patients,

(1996;) Dose the assessment of serum markers in patients with lung cancer aid in the clinical decision making process,

(1990) Serum neuron- specific enolase is useful marker for small cell lung cancer,

(1999) Tumor markers CEA, NSE, SCC, TPA and Cypra 21.1 in resectable non-small cell lung cancer,

(1993) Neuroendocrine characteristics in bronchogenic adenocarcinoma and its clinical re levance,

(2001) Cyfra 21- 1, euron specific enolase and prognosis of non-small cell lung cancer prospective study in 621 patient,

(1992) Serum neuron enolase(NSE)levels in patients with non small cell lung ca ncer,

(2003) Neuron-specific enolase is an effective tumour marker in non-small cell lung cancer(NSCLC),

(1982) Pathology of carcinoma of the lung:changing patterns, Clin Chest Med

Phenotypic heterogeneity studied by immunohistochemistry and aneuploidy in non- small cell lung cancers,